Publications by authors named "C Batard"
Article Synopsis
- Respiratory syncytial virus (RSV) is a major cause of lower respiratory infections in children, and a new monoclonal antibody, nirsevimab, was introduced in September 2023 to combat RSV.
- A study was conducted on infants under 12 months old to evaluate the effectiveness of nirsevimab against RSV-bronchiolitis in outpatient settings, involving a comparison between RSV-positive and RSV-negative bronchiolitis patients.
- The findings showed that nirsevimab reduced the risk of RSV-bronchiolitis by 79.7%, indicating its effectiveness in preventing this infection in young children during outpatient care.
(1) Background: While goat milk formula (GMF) is an alternative to cow milk formula (CMF), infants' preferences for one over the other have not been formally assessed. Specifically, our aim in this study was to determine whether infants experience fewer feeding behavior problems with whole milk-based GMF than with conventional whey-based CMF. (2) Methods: This was a multicenter, double-blind, randomized controlled trial with two-arm parallel assignment conducted in six pediatricians' offices in or near Paris, France, between June 2018 and 31 December 2021.
View Article and Find Full Text PDFEpidemiological surveillance of nasopharyngeal pneumococcal carriage is important for monitoring serotype distribution and antibiotic resistance, particularly before and after the implementation of pneumococcal conjugate vaccines (PCVs). With a prospective surveillance study in France, we aimed to analyze the dynamics of pneumococcal carriage, antibiotic susceptibility and serotype distribution in children aged 6 to 24 months who had acute otitis media between 2001 and 2022 with a focus on the late PCV13 period from May 2014 to July 2022. Trends were analyzed with segmented linear regression with autoregressive error.
View Article and Find Full Text PDFObjectives: The aim of this study was to describe the bacterial profile of middle ear fluid from spontaneous perforation of the tympanic membrane (SPTM) prior to widespread utilization of third- generation pneumococcal conjugate vaccines (PCVs).
Patients And Methods: From October 2015 to January 2023, children with SPTM were prospectively enrolled by pediatricians.
Results: Among the 852 children with SPTM, 73.